Prostate News and Research

RSS

High-throughput genetic analysis can help dissect the mechanism of disease inheritance

Many genetic variants have been found to have a linkage with genetic diseases, but the understanding of their functional roles in causing diseases are still limited.

24 Feb 2021

Polygenic hazard score improves prediction of prostate cancer risk in multi-ethnic populations

Building upon previous research, an international team led by scientists at University of California San Diego School of Medicine, has validated a more inclusive and comprehensive genetic tool for predicting age of onset of aggressive prostate cancer, a disease that killed more than 33,000 American men in 2020.

23 Feb 2021

Drugs for benign prostatic hyperplasia associated with increased risk of cardiac failure

Widely used medications for benign prostatic hyperplasia (BPH) - also known as enlarged prostate - may be associated with a small, but significant increase in the probability of developing heart failure, suggests a study in The Journal of Urology, Official Journal of the American Urological Association.

22 Feb 2021

Researchers urge European policymakers to make adequate resources available to tackle pancreatic cancer

Researchers have called on European policymakers to make adequate resources available to tackle pancreatic cancer, a disease that is almost invariably fatal and where little progress has been made over the past 40 years.

21 Feb 2021

Psychosocial factors may contribute to dropout of patients from peritoneal dialysis

A retrospective study conducted by LSU Health New Orleans reports that contrary to previous research, most patients who drop out of peritoneal dialysis may do so for psychosocial reasons.

20 Feb 2021

Targeting MAPK4 enzyme may be a potential new strategy to combat prostate cancer

The battle against late-stage prostate cancer might have found a potential new strategy to combat this deadly disease.

20 Feb 2021

Physical comorbidity is associated with high psychological distress

Among patients with cancer, having additional physical comorbidities was linked with a higher risk of experiencing psychological distress. The finding comes from a Psycho-Oncology analysis of 2017 data from the National Health Survey of Spain.

18 Feb 2021

New type of leaky wave MRI antenna is an all-round talent

Magnetic resonance imaging (MRI) at 7 tesla is the latest generation of this technology and offers images with a significantly higher-resolution than the classic devices, working with a maximum magnetic flux density of 3 tesla.

17 Feb 2021

Researchers track how Osmium reacts in a single cancer cell

Osmium is a rare precious metal that could be used to treat cancer with fewer side effects when compared to Platinum, currently used in nearly half of chemotherapies.

17 Feb 2021

Researchers identify molecular link between inflammatory signaling molecule and a main oncogene

A team of MedUni Vienna researchers led by Johannes A. Schmid at the Center for Physiology and Pharmacology, Institute of Vascular Biology and Thrombosis Research, has managed to identify a previously unknown molecular connection between an inflammatory signaling molecule and one of the main oncogenes.

17 Feb 2021

Mathematical model reveals how cell turnover determines the success of adaptive therapy

One of the most challenging issues in cancer therapy is the development of drug resistance and subsequent disease progression.

17 Feb 2021

Scientists examine DNA repair pathways and their impact on cancer evolution

DNA repair pathways exist to correct molecular damage caused by internal and external factors. However, any damage to these pathways can result in the creation of tumors and specific types of cancers.

17 Feb 2021

New model predicts which patients will gain most from PSMA PET scan

A new study led by researchers at the UCLA Jonsson Comprehensive Cancer Center helps identify which patients with prostate cancer will benefit most from the use of prostate-specific membrane antigen PET imaging, PSMA PET, a novel imaging technique that recently was approved by the U.S. Food and Drug Administration.

16 Feb 2021

Study: Radioactive bone cement is a safer alternative for treating bone tumors

A radioactive bone cement that's injected into bone to provide support and local irradiation is proving to be a safer alternative to conventional radiation therapy for bone tumors, according to a study led by University of California, Irvine researchers.

16 Feb 2021

Liquid biopsy can help gauge the effectiveness of therapy for colorectal cancer

A new study from Washington University School of Medicine in St. Louis demonstrates that a liquid biopsy examining blood or urine can help gauge the effectiveness of therapy for colorectal cancer that has just begun to spread beyond the original tumor.

14 Feb 2021

New urine test could avoid unnecessary prostate cancer biopsies

A urine test based on University of Michigan Rogel Cancer Center research could have avoided one third of unnecessary prostate cancer biopsies while failing to detect only a small number of cancers, according to a validation study that included more than 1,500 patients.

11 Feb 2021

Genomic test may help guide treatment decisions for patients with recurrent prostate cancer

A commercially available genomic test may help oncologists better determine which patients with recurrent prostate cancer may benefit from hormone therapy, according to new research from the Johns Hopkins Kimmel Cancer Center and 15 other medical centers.

11 Feb 2021

Researchers analyze overall survival rate of prostate cancer patients treated with melatonin

Oncotarget recently published "Melatonin increases overall survival of prostate cancer patients with poor prognosis after combined hormone radiation treatment" which reported that a retrospective study included 955 patients of various stages of prostate cancer who received combined hormone radiation treatment from 2000 to 2019.

11 Feb 2021

Study reveals why Black men with prostate cancer have greater survival benefits from immunotherapy

Black men die more often of prostate cancer yet, paradoxically, have greater survival benefits from immunotherapy treatment.

10 Feb 2021

Study shows efficacy of radionuclide therapy–immunotherapy combination in prostate cancer model

A combination of radionuclide therapy and immunotherapy has proven successful in slowing the progression of prostate cancer and increasing survival time, according to new research published in the February issue of The Journal of Nuclear Medicine.

8 Feb 2021

Prostate News and Research

High-throughput genetic analysis can help dissect the mechanism of disease inheritance

Polygenic hazard score improves prediction of prostate cancer risk in multi-ethnic populations

Drugs for benign prostatic hyperplasia associated with increased risk of cardiac failure

Researchers urge European policymakers to make adequate resources available to tackle pancreatic cancer

Psychosocial factors may contribute to dropout of patients from peritoneal dialysis

Targeting MAPK4 enzyme may be a potential new strategy to combat prostate cancer

Physical comorbidity is associated with high psychological distress

New type of leaky wave MRI antenna is an all-round talent

Researchers track how Osmium reacts in a single cancer cell

Researchers identify molecular link between inflammatory signaling molecule and a main oncogene

Mathematical model reveals how cell turnover determines the success of adaptive therapy

Scientists examine DNA repair pathways and their impact on cancer evolution

New model predicts which patients will gain most from PSMA PET scan

Study: Radioactive bone cement is a safer alternative for treating bone tumors

Liquid biopsy can help gauge the effectiveness of therapy for colorectal cancer

New urine test could avoid unnecessary prostate cancer biopsies

Genomic test may help guide treatment decisions for patients with recurrent prostate cancer

Researchers analyze overall survival rate of prostate cancer patients treated with melatonin

Study reveals why Black men with prostate cancer have greater survival benefits from immunotherapy

Study shows efficacy of radionuclide therapy–immunotherapy combination in prostate cancer model

What to know about prostate cancer eBook

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News